肝肺症候群 HPS
WordNet
- a pattern of symptoms indicative of some disease
- a complex of concurrent things; "every word has a syndrome of meanings"
PrepTutorEJDIC
- (疾患の徴候となる一群の)症徴候,症候群 / (事件・社会的状態などのパターンを示す)徴候形態
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/06/06 22:46:52」(JST)
[Wiki en表示]
In medicine, hepatopulmonary syndrome is a syndrome of shortness of breath and hypoxemia (low oxygen levels in the blood of the arteries) caused by vasodilation (broadening of the blood vessels) in the lungs of patients with liver disease. Dyspnea and hypoxemia are worse in the upright position (which is called platypnea and orthodeoxia, respectively).
Contents
- 1 Pathophysiology
- 2 Diagnosis
- 3 Treatment
- 4 Prognosis
- 5 See also
- 6 References
- 7 Further reading
Pathophysiology
The hepatopulmonary syndrome results from the formation of microscopic intrapulmonary arteriovenous dilatations in patients with both chronic and acute liver failure. The mechanism is unknown but is thought to be due to increased hepatic production or decreased hepatic clearance of vasodilators, possibly involving nitric oxide.[1]
The vascular dilatations cause overperfusion relative to ventilation, leading to ventilation-perfusion mismatch and hypoxemia. There is an increased gradient between the partial pressure of oxygen in the pulmonary alveoli and adjacent arteries (alveolar-arterial [A-a] gradient) while breathing room air. Additionally, late in cirrhosis, it is common to develop high output failure, which would lead to less time in capillaries per red blood cell, exacerbating the hypoxemia.
Diagnosis
The hepatopulmonary syndrome is suspected in any patient with known liver disease who reports dyspnea (particularly platypnea). Patients with clinically significant symptoms should undergo pulse oximetry. If the syndrome is advanced, arterial blood gasses should be measured on air.[citation needed]
A useful diagnostic test is contrast echocardiography. Intravenous microbubbles (> 10 micrometers in diameter) from agitated normal saline that are normally obstructed by pulmonary capillaries (normally <8 to 15 micrometers) rapidly transit the lung and appear in the left atrium of the heart within 7 heart beats. Similarly, intravenous technetium-99m–labeled albumin may transit the lungs and appear in the kidney and brain. Pulmonary angiography may reveal diffusely fine or blotchy vascular configuration. The distinction has to be made with an intracardiac right-to-left shunt.[citation needed]
Treatment
Currently the only definitive treatment is liver transplantation.[2] Alternative treatments such as supplemental oxygen or somatostatin to inhibit vasodilation remain anecdotal.
Prognosis
With liver transplantation, the 5 year survival rate is 76%, which is comparable to patients who undergo liver transplants who do not suffer from hepatopulmonary syndrome.[3]
See also
- Gastric antral vascular ectasia
- Hepatitis
References
- ^ Rodríguez-Roisin, MD, Roberto. "Hepatopulmonary Syndrome — A Liver-Induced Lung Vascular Disorder". New England Journal of Medicine. Retrieved 2 March 2011.
- ^ Rodriguez-Roisin, R; Krowka MJ (Rodriguez-Roisin R, Krowka MJ. Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach. Eur Respir J 1994;7:839-842). "Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation?". European Respiratory Journal 7 (5): 839–842. PMID 8050537. Retrieved 2 March 2011.
- ^ Swanson, KL; Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005;41:1122-1129 (12 April 2005). "Natural history of hepatopulmonary syndrome: impact of liver transplantation". Hepatology 41 (5): Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005;41:1122–1129. doi:10.1002/hep.20658. PMID 15828054.
Further reading
- Rodríguez-Roisin, Roberto; Krowka, Michael J. (29 May 2008). "Hepatopulmonary Syndrome — A Liver-Induced Lung Vascular Disorder". New England Journal of Medicine 358 (22): 2378–2387. doi:10.1056/NEJMra0707185. PMID 18509123.
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Pulmonary function-morphologic relationships assessed by SPECT-CT fusion images.
- Suga K.SourceDepartment of Radiology, St. Hill Hospital, 3-7-18 Imamura-Kita, Ube, Yamaguchi, 755-0151, Japan, sugar@sthill-hp.or.jp.
- Annals of nuclear medicine.Ann Nucl Med.2012 Feb 18. [Epub ahead of print]
- Pulmonary single photon emission computed tomography-computed tomography (SPECT-CT) fusion images provide objective and comprehensive assessment of pulmonary function and morphology relationships at cross-sectional lungs. This article reviewed the noteworthy findings of lung pathophysiology in wide-
- PMID 22350957
- Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans.
- Koch DG, Bogatkevich G, Ramshesh V, Lemasters JJ, Uflacker R, Reuben A.SourceDivision of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, ART 7100A, 25 Courtenay Dr. MSC 290, Charleston, SC 29425, USA. kochd@musc.edu
- Digestive diseases and sciences.Dig Dis Sci.2012 Feb;57(2):516-23. Epub 2011 Oct 1.
- BACKGROUND: Hepatopulmonary syndrome is a pulmonary vascular complication of cirrhosis in which intrapulmonary vasodilatation (IPV) results in hypoxemia. Endothelin-1 (ET-1), produced by proliferating cholangiocytes, has been identified as a mediator of IPV in an animal model of HPS, but the pathoph
- PMID 21964742
Japanese Journal
- 脳膿瘍を合併した肝肺症候群が併存した間質性肺炎の1例
- 柳原 豊史,森脇 篤史,関 七重,赤田 憲太朗,今永 知俊
- 日本呼吸器学会雑誌 = The journal of the Japanese Respiratory Society 49(7), 534-537, 2011-07-10
- NAID 10029372443
- Reversal of Severe Hepatopulmonary Syndrome in Chronic Hepatic Cirrhosis by Living Donor Liver Transplantation : Report of Two Cases
- CHEN KEFEI,LI BO
- Surgery today : the Japanese journal of surgery 41(3), 441-443, 2011-03-01
- NAID 10029046364
Related Links
- 2010年1月25日 ... 肝臓に一義的原因があり合併症として呼吸器系に障害をきたす病態がある。肝不全の 随伴症候としての腹水・肝性胸水や、貧血、筋疲労による呼吸困難、さらには低栄養 による易感染状態から肺炎を生じることまでは容易に推測できるが、 ...
- In medicine, hepatopulmonary syndrome is a syndrome of shortness of breath and hypoxemia (low oxygen levels in the blood of the arteries) caused by vasodilation (broadening of the blood vessels) in the lungs of patients with liver disease.
Related Pictures
★リンクテーブル★
[★]
- 英
- hepatopulmonary syndrome HPS
- 明らかな心肺疾患がないにもかかわらず、肝疾患・門脈亢進症の患者において、肺内血管拡張をきたし低酸素血症を呈する病態。治療は確立されておらず、重症例を除いて肝移植が唯一有効。(SSUR.594)
参考
[★]
[★]